Results 41 to 50 of about 1,056,689 (199)

The spectrum of Progressive Familial Intrahepatic Cholestasis diseases:Update on pathophysiology and emerging treatments [PDF]

open access: yes, 2021
The Progressive Familial Intrahepatic Cholestasis (PFIC) disease spectrum encompasses a variety of genetic diseases that affect the bile production and the secretion of bile acids. Typically, the first presentation of these diseases is in early childhood,
Verkade, Henkjan J; id_orcid   +3 more
core   +1 more source

Partial internal biliary diversion for patients with progressive familial intrahepatic cholestasis type 1 [PDF]

open access: yes, 2011
We herein report a case of progressive familial intrahepatic cholestasis with partial internal biliary diversion (PIBD). Although by using PIBD an external stoma can be avoided, exposure of the ileocecal junction to bile reflux as well as the effects of ...
Takatsuki, Mitsuhisa   +13 more
core   +2 more sources

Partial External Biliary Diversion for Severe Diarrhea After Liver Transplant in Patients with Progressive Familial Intrahepatic Cholestasis Type 1

open access: yes, 2022
© Başkent University 2022 Printed in Turkey. All Rights Reserved.Progressive familial intrahepatic cholestasis is a heterogeneous group of autosomal recessive disorders, and liver transplant is the only curative treatment.
SARI, SİNAN   +5 more
core   +1 more source

Newer variants of progressive familial intrahepatic cholestasis

open access: yesWorld Journal of Hepatology, 2021
Progressive familial intrahepatic cholestasis (PFIC) is a heterogeneous group of disorders characterized by defects in bile secretion and presentation with intrahepatic cholestasis in infancy or childhood. The most common types include PFIC 1 (deficiency of FIC1 protein, ATP8B1 gene mutation), PFIC 2 (bile salt export pump deficiency, ABCB11 gene ...
Vinayagamoorthy, Vignesh   +2 more
openaire   +2 more sources

Long-Term Outcomes of Patients With Progressive Familial Intrahepatic Cholestasis After Biliary Diversion

open access: yes, 2022
Objectives: Progressive familial intrahepatic cholestasis is a heterogeneous group of genetic disorders characterized by disrupted bile homeostasis.
SARI, SİNAN   +5 more
core   +1 more source

Liver Transplantation for Progressive Familial Intrahepatic Cholestasis [PDF]

open access: yesAnnals of Transplantation, 2018
BACKGROUND Progressive familial intrahepatic cholestasis (PFIC) is an autosomal recessive inherited disease that disrupts the genes for bile formation. Liver transplantation (LT) is the only effective treatment for PFIC patients with end-stage liver disease.
Liu, Ying   +5 more
openaire   +2 more sources

Gene therapy for progressive familial intrahepatic cholestasis type 3 in a clinically relevant mouse model

open access: yesNature Communications, 2019
Progressive familial intrahepatic cholestasis type 3 is a disease caused by mutations in the gene encoding the multidrug resistance protein 3, and has limited treatment options.
Nicholas D. Weber   +7 more
doaj   +1 more source

Case Report: A Rare Heterozygous ATP8B1 Mutation in a BRIC1 Patient: Haploinsufficiency?

open access: yesFrontiers in Medicine, 2022
Benign recurrent intrahepatic cholestasis (BRIC) is an autosomal recessive disorder characterized by recurrent cholestasis. ATPase class I, type 8B, member 1 (ATP8B1) encodes familial intrahepatic cholestasis 1 (FIC1), which acts as a phosphatidylserine ...
Hao Bing   +5 more
doaj   +1 more source

Familial intrahepatic cholestasis: New and wide perspectives

open access: yes, 2019
Background: Progressive familial intrahepatic cholestasis (PFIC) includes autosomal recessive cholestatic rare diseases of childhood. Aims: To update the panel of single genes mutations involved in familial cholestasis.
Raimondi F.   +10 more
core   +1 more source

Dilated cardiomyopathy and progressive familial intrahepatic cholestasis [PDF]

open access: yesBMJ Case Reports, 2014
This case is of a 29-year-old man with progressive familial intrahepatic cholestasis type 1 also known as Byler's disease. At the age of 21, our patient developed non-ischaemic dilated cardiomyopathy. Cardiac MRI demonstrated global wall thinning, with significant areas of myocardial fibrosis in the mid and epicardial walls from base to apex on ...
Stephanie, James   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy